Venlafaxine treatment of cocaine abusers with depressive disorders

American Journal of Drug and Alcohol Abuse

Volumn 26, Issue 1, 2000, Pages 25-31

  McDowell, David M ^a,b   Levin, Frances R ^a   Seracini, Angela M ^a   Nunes, Edward V ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DESIPRAMINE; PERGOLIDE; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HUMAN; MALE; MOOD; RELAPSE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; COCAINE-RELATED DISORDERS; COMORBIDITY; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DESIPRAMINE; DIAGNOSIS, DUAL (PSYCHIATRY); DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT FAILURE;

EID: 0034048909     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.1081/ADA-100100588     Document Type: Article

References (23)

1. Gawin, F. H., and Kleber, H. D., Abstinence symptomatology and psychiatric diagnosis in cocaine abusers, Arch. Gen. Psychiatry 46:117-121 (1986).
2. Weiss, R. D., Mirin, S. M., Michael, J. L., et al., Psychopathology in chronic cocaine abusers, Am. J. Drug Alcohol Abuse 12:17-29 (1986).
3. Nunes, E. V., Quitken, F. M., and Klein, D. F., Psychiatric diagnosis in cocaine abuse, Psychiatry Res. 28:105-114 (1989).
4. Carroll, K. M., Nich, C., and Rounsaville, B. J., Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy. J. Nerv. Ment. Dis. 183:251-259 (1995).
5. Carroll, K. M., Power, M. E., Bryant, K., et al., One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome, J. Nerv. Ment. Dis. 181:71-79 (1993).
6. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Author, Washington, DC, 1994.
7. Margolin, A., Kosten, T. R., Avants, S. K., et al., A multicenter trial of buproprion for cocaine dependence in methadone maintained patients, Drug Alcohol Depend. 40:125-131 (1995).
8. Nunes, E. V., Quitkin, F. M., Brady, R., et al., Antidepressant treatment in methadone maintenance patients, J. Addict. Dis. 13:13-24 (1994).
9. Zeidonis, D. M., and Kosten, T. R., Depression as a prognostic factor for pharmacological treatment of cocaine dependence, Psychopharmacol. Bull., 27:337-343 (1991).
10. Arndt, I. O., Dorozynsky, L., Woody, G. E., et al., Desipramine treatment of cocaine dependence in methadone-maintenance patients, Arch. Gen. Psychiatry 49:888-893 (1992).
11. Carroll, K. M., Rounsaville, B. J., Gordon, L. T., et al. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers, Arch. Gen. Psychiatry 51:177-187 (1994).
12. Nunes, E. V., McGrath, P. J., Quitkin, F. M., et al., Imipramine treatment of cocaine abuse; possible boundaries of efficacy, Drug Alcohol Depend. 39:185-195 (1995).
13. Nunes, E. V., McGrath, P. J., Quitken, F. M., et al., Imipramine treatment of alcoholism with comorbid depression, Am. J. Psychiatry 150:963-965 (1993).
14. Mason, B. J., Kocsis J. H., Ritvo, E. C., et al., A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence and stratified on the presence or absence of major depression, JAMA 275:761-767 (1996).
15. McGrath, P. J., Nunes, E. V., Stewart J. W., et al., Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial, Arch. Gen. Psychiatry 53:232-240 (1996).
16. Woody, G., McClellan, T., and Bedrick, J., Dual diagnosis, in Review of Psychiatry, Vol. 14 (J. M. Oldham and M. B. Riba, Eds.), APA Press, Washington, DC, 1995, pp. 83-103.
17. Nunes, E. V., Deliyannides, D., Donovan, S., et al., The management of trealment-resistance in depressed patients with substance use disorders, Psychiatric Clin. North Am. (1998).
18. Ellingrod, V. L., and Perry, P. J., Venlafaxine: a heterocyclic antidepressant, Am. J. Hosp. Pharmacol. 51:3033-3046 (1994).
19. Quitkin, F. M., McGrath, P. J., Stewart, J. W., et al., Can the effects of antidepressants be observed in the first two weeks of treatment? Neuropsychopharmacology 15(4):390-394 (1996).
20. Nunes, E. V., Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective, NIDA Res. Monogr. 175:73-95 (1997).
21. Augustin, B. G., Cold, J. A., and Jann, M. W., Venlafaxine and nefazodone, two pharmacologically distinct antidepressants, Pharmacotherapy 17(3):511-530 (1997).
22. Guelfi, J. D., White, C., Hackett, D., Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia, J. Clin. Psychiatry 56:450-458 (1995).
23. Marcou, A., Kosten, T. R., and Koob, G. F., Neurobiological similarities in depression and drug dependence: a self-medication hypothesis, Neuropsychopharmacology 18:135-174 (1998).